Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

316
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
316
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

300
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

476
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
476
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

790
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
790
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

391
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
391
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

377
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
377

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptomatic Left Main Coronary Artery Aneurysm With Intraluminal Thrombus.

Annals of thoracic surgery short reports·2025
Same author

Mitigating Risk in TAVR: Do Rankings Influence Patient Selection?

JACC. Cardiovascular interventions·2025
Same author

Evolution of TAVR as a Technology: Do Real-World Outcomes Still Support Expanded Use?

Circulation·2025
Same author

Aortic shape and diameter variations are predictive of short-term complications in transcatheter aortic valve replacement.

The international journal of cardiovascular imaging·2025
Same author

Peroxisome proliferator-activated receptor gamma ( <i>PPARG</i> )-mediated myocardial salvage in acute myocardial infarction managed with left ventricular unloading and coronary reperfusion.

bioRxiv : the preprint server for biology·2025
Same author

Ventricular Reconstruction: A Sledgehammer for a Hammer's Work?

JACC. Heart failure·2025

Related Experiment Video

Updated: Feb 16, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

620

Managing Stenotic Septal Perforator Branches.

Abdulfattah Saidi, Anwar Tandar, Frederick G P Welt

    Texas Heart Institute Journal
    |December 21, 2017
    PubMed
    Summary

    Treating obstructive septal perforator branch stenosis in coronary artery disease is challenging due to small vessel size. This case series explores the management and outcomes of percutaneous interventions in these difficult-to-access coronary arteries.

    Keywords:
    Angioplasty, balloon, coronary/methodsatherectomy, coronarycoro nary circulation/physiologycoronary occlusion/etiology/therapycoronary stenosis/therapycoronary vessels/pathologyrisk factorsstentstreatment outcome

    More Related Videos

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
    07:39

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

    Published on: August 16, 2021

    4.2K
    Novel and Innovative Hybrid Technique for Type A Aortic Dissection
    06:26

    Novel and Innovative Hybrid Technique for Type A Aortic Dissection

    Published on: March 28, 2025

    1.0K

    Related Experiment Videos

    Last Updated: Feb 16, 2026

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
    06:59

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

    Published on: August 26, 2025

    620
    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
    07:39

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

    Published on: August 16, 2021

    4.2K
    Novel and Innovative Hybrid Technique for Type A Aortic Dissection
    06:26

    Novel and Innovative Hybrid Technique for Type A Aortic Dissection

    Published on: March 28, 2025

    1.0K

    Area of Science:

    • Cardiology
    • Interventional Cardiology
    • Vascular Biology

    Background:

    • Septal perforator branches are crucial for myocardial blood supply.
    • Disease in these vessels can cause ischemia and conduction issues.
    • Interventional approaches are limited by small vessel size and accessibility.

    Observation:

    • Obstructive stenosis in septal perforator branches presents a therapeutic challenge.
    • Percutaneous treatment of larger septal perforator branches has been attempted.
    • Clinical effectiveness and long-term outcomes of these interventions remain largely unknown.

    Findings:

    • This study presents the management experience in 4 patients with obstructive septal perforator branch stenosis.
    • The focus is on the feasibility and approach to interventional procedures in these small vessels.
    • Detailed outcomes and long-term follow-up data are crucial for evaluating this approach.

    Implications:

    • Successful management of septal perforator branch stenosis could improve outcomes for specific coronary artery disease patients.
    • Further research is needed to establish the clinical effectiveness and long-term safety of percutaneous interventions.
    • Developing specialized techniques and equipment may enhance treatment possibilities for these challenging lesions.